Several AICR-funded researchers came to our conference last week to present their latest findings in the poster session:
Dr. Emmanuel T. Akporiaye of the Robert W. Franz Cancer Research Center in Portland, Oregon, updated us on the progress of his grant examining the effect of a derivative of vitamin E on breast cancer tumors. (Earlier this year, we profiled Dr. A in AICR’s biweekly e-newsletter Cancer Research Update. A longer version of that interview appeared in this Summer’s AICR ScienceNow newsletter.)
Dr. Nameer B. Kirma of the University of Texas Health Science Center in San Antonio presented data from his work with soy components and breast cancer.
Dr. Meghan M. Mensack is using an AICR grant at the Colorado State University to study the anti-cancer potential of the common bean (Phaseolus vulgaris L)
Lots more AICR-funded scientists, after the jump.
Dr. Laura Hale of Duke talked about some exciting results from her grant involving bromelain, a compound find in pineapples, and its effectiveness against the kind of inflammation that can lead to colon cancer. (Check out our video interview with her.)
Dr. Denise O’Keefe of the University of Pittsburgh presented findings from her AICR grant examining the metabolism of prostate cancer patients.
Dr. Penelope Webb presented the session’s only poster on esophageal cancer. Her AICR grant is looking at how high folate intake impacts the risk of esophageal cancer.
Dr. Susan Lanza- Jacoby of Thomas Jefferson University in Philadelphia presented findings from her AICR-funded investigation, which involves an herb used in traditional Chinese medicine, Phellodandron amurense. She’s looking at the potential of this herb to protect against pancreatic cancer.
Dr. Lauri Byerley of the University of North Carolina at Charlotte is using an AICR grant to investigate a substance in the blood which may play an important role in cancer cachexia.
Dr. Elaine Hardman of Marshall University in West Virginia presented her latest work with omega 3 fatty acids and the kind of malignancies that can lead to multiple myeloma and leukemia. Last year, her AICR-funded work showing the potential of walnuts to slow the growth of breast cancer tumors made international news. We wrote about it in Cancer Research Update.
Dr. Marion Chan of Rutgers presented her AICR-supported research with curcumin (the compound that lends turmeric its brilliant yellow color) and cancer stem cells. (Curcumin is the front-page story of the latest AICR ScienceNow newletter.)
And AICR grantee Dr John Saxton presented a poster on his exercise intervention trial with breast cancer survivors.